It is well known that initially low and decreasing CD4+ cell counts during the year prior to cancer diagnosis are predictive of AIDS-defining malignancies (ADMs) such as Kaposi sarcoma and non-Hodgkin lymphoma as shown in the CASCADE study [150]. Here, CD4 is linked to non-Hodgkin lymphoma.